Summary
The product Clomimed 50, manufactured by Deus Medical, was tested to determine its content and dosage accuracy. The sample, identified by batch number DM52894 with a manufacturing date of October 2020, underwent analysis for clomiphene citrate content. The results revealed an average clomiphene citrate concentration of 49.18 mg per pill, with slight variation between two pills tested (49.65 mg and 48.72 mg).
Testing was conducted on 21 November 2020, with the sample submitted and paid for by the reseller DEUSPOWER.SHOP. These findings confirm the product meets its label claim of 50 mg per pill with minimal variance, ensuring consistency.
Detailed Report
Product Overview
- Manufacturer: Deus Medical
- Product Name: Clomimed 50
- Active Ingredient: Clomiphene Citrate
- Batch Number: DM52894
- Manufacture Date: October 2020
- Delivery Method: Oral (pill)
Sample Acquisition and Testing
- Task Number: #09151
- Testing Ordered: 13 November 2020
- Sample Received: 18 November 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DEUSPOWER.SHOP (Reseller)
- Analysis Paid For By: DEUSPOWER.SHOP (Reseller)
Testing Results
- Specification: 50 mg/pill Clomiphene Citrate (as stated on the label)
- Measured Concentration:
- First Pill: 49.65 mg
- Second Pill: 48.72 mg
- Average: 49.18 mg/pill
- Accuracy: 98.36% of the label claim
- Variance: -1.64%
Verification Details
- Verification URL: https://janoshik.com/tests/09151_1EPRWF7P3F8Q
- Originally Published: https://thinksteroids.com/community/forums/analytical-lab-testing/
Evaluation of Reseller-Funded Testing
The analysis was funded and submitted by DEUSPOWER.SHOP, a reseller, which could introduce potential bias. Reseller-funded testing might involve selective sample submissions. However, Janoshik Analytical’s rigorous methodology and reputation for accuracy lend credibility to the findings. Users are encouraged to cross-reference these results with independent testing data when possible.
Conclusion
The analysis of Clomimed 50 by Deus Medical confirms the product’s content accuracy, with a measured concentration very close to the label claim. This demonstrates consistency and quality, providing confidence for consumers. These findings are valuable for educational and harm reduction purposes.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
